These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 6875025)

  • 21. [Monitoring of the treatment of endogenous depression with imipramine and amitriptyline (preliminary report)].
    Rybakowski J; Matkowski K; Linka M; Kasprowicz-Dabrowiecka A; Kanarkowski R; Lehmann W; Krzyzanowski M
    Psychiatr Pol; 1991; 25(3-4):111-8. PubMed ID: 1821970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The comparative efficacy of Aurorix and amitriptyline in treating depressions].
    Iakovlev VA
    Voen Med Zh; 1997 Apr; 318(4):37-8. PubMed ID: 9221592
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative effectiveness of detoxification hemosorption and electroconvulsive therapy in patients with endogenous depression resistant to tricyclic antidepressants].
    Kosov NE; Mosolov SN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):74-8. PubMed ID: 1650104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prediction of the effect of antidepressants in patients with endogenous depression].
    Litvinova NM; Kabachenko EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):577-82. PubMed ID: 3716710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dexamethasone suppression test in the identification subtypes of depression differentially responsive to antidepressants [proceedings].
    Brown WA; Haier RJ; Qualls CB
    Psychopharmacol Bull; 1981 Jan; 17(1):88-90. PubMed ID: 7232667
    [No Abstract]   [Full Text] [Related]  

  • 26. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of psychiatric disorders in the aged].
    Jacoby R; Harwin B
    Recenti Prog Med; 1978 Aug; 65(2):153-70. PubMed ID: 362497
    [No Abstract]   [Full Text] [Related]  

  • 28. Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression--a double-blind controlled study.
    Shahal B; Piel E; Mecz L; Kremer I; Klein E
    Biol Psychiatry; 1996 Dec; 40(11):1181-3. PubMed ID: 8931923
    [No Abstract]   [Full Text] [Related]  

  • 29. RDC endogenous depression as a predictor of response to antidepressant drugs and psychotherapy.
    Klerman GL; Weissman MM; Prusoff BA
    Adv Biochem Psychopharmacol; 1982; 32():165-74. PubMed ID: 7090892
    [No Abstract]   [Full Text] [Related]  

  • 30. Urinary MHPG is not a good predictor of antidepressive drug response.
    Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M
    Pol J Pharmacol Pharm; 1984; 36(4):329-35. PubMed ID: 6527968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of depression in the elderly.
    Grossberg GT; Nakra BR
    Compr Ther; 1986 Oct; 12(10):16-22. PubMed ID: 2877765
    [No Abstract]   [Full Text] [Related]  

  • 32. Antidepressive treatment and mood swing patterns in endogenous depression.
    Strian F; Albert W; Klicpera C
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):432-7. PubMed ID: 538088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Who benefits from tricyclic antidepressants: a survey.
    Goldberg SC; Tilley DH; Friedel RO; Hamer RM; Ban TA; Brockett C; Bale P; Stephens V
    J Clin Psychiatry; 1988 Jun; 49(6):224-8. PubMed ID: 3379027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoxetine and desipramine: a strategy for augmenting anti-depressant response.
    Eisen A
    Pharmacopsychiatry; 1989 Nov; 22(6):272-3. PubMed ID: 2616636
    [No Abstract]   [Full Text] [Related]  

  • 35. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.
    Goodwin FK; Prange AJ; Post RM; Muscettola G; Lipton MA
    Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.
    Kocsis JH; Croughan JL; Katz MM; Butler TP; Secunda S; Bowden CL; Davis JM
    Am J Psychiatry; 1990 May; 147(5):621-4. PubMed ID: 2183635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Threshold stimulus ECT.
    Mayur PM; Kumar TC; Seshadri SP; Gangadhar BN
    J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1488. PubMed ID: 9394928
    [No Abstract]   [Full Text] [Related]  

  • 38. The clinical characteristics and treatment of atypical depression.
    Sovner RD
    J Clin Psychiatry; 1981 Jul; 42(7):285-9. PubMed ID: 7240114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of age-related effectiveness of tri- and tetracyclic antidepressants].
    Kontsevoĭ VA; Kolibash E; Piatnitskiĭ AN; Korzhinkova V; Andrusenko MP; Kostrikina IE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):58-65. PubMed ID: 1664617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbamazepine for treatment-resistant melancholia.
    Cullen M; Mitchell P; Brodaty H; Boyce P; Parker G; Hickie I; Wilhelm K
    J Clin Psychiatry; 1991 Nov; 52(11):472-6. PubMed ID: 1744065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.